Committed to responsible pain management

Developing innovative and differentiated products for people suffering from pain

At Collegium Pharmaceutical we are committed to being the leader in responsible pain management. We have developed a portfolio of meaningfully differentiated products for use in the treatment of moderate-to-severe pain.

News and Press

Join the Collegium team

News and Press

  • Collegium Announces Four Posters Presented at PAINWeek 2021 National Conference

    Read More
  • Collegium to Participate in Upcoming Investor Conferences

    Read More
  • Collegium Announces $100 Million Share Repurchase Program

    Read More
  • Collegium Reports Strong Q2 Results with Cash Balance Growing to Over $200 Million

    Read More